AE, P., X, X., TE, H., AM, H., CJ, M., GC, A., & HB, M. (2025). Comparative Effectiveness of Baricitinib Versus Tocilizumab in Hospitalized Patients With COVID-19: A Retrospective Cohort Study of the National Covid Collaborative. Critical care medicine, 53(1), e29. https://doi.org/10.1097/CCM.0000000000006444
Chicago Style (17th ed.) CitationAE, Patanwala, Xiao X, Hills TE, Higgins AM, McArthur CJ, Alexander GC, and Mehta HB. "Comparative Effectiveness of Baricitinib Versus Tocilizumab in Hospitalized Patients With COVID-19: A Retrospective Cohort Study of the National Covid Collaborative." Critical Care Medicine 53, no. 1 (2025): e29. https://doi.org/10.1097/CCM.0000000000006444.
MLA (9th ed.) CitationAE, Patanwala, et al. "Comparative Effectiveness of Baricitinib Versus Tocilizumab in Hospitalized Patients With COVID-19: A Retrospective Cohort Study of the National Covid Collaborative." Critical Care Medicine, vol. 53, no. 1, 2025, p. e29, https://doi.org/10.1097/CCM.0000000000006444.